Chemours Company (CC) reported $5.84B of revenue for the twelve months ended Sep 30, 2026. That is up 0.1% from the year before. Revenue for fiscal 2025 was $5.81B.

No. Chemours Company reported a net loss of $154.00M for the twelve months ended Sep 30, 2026.

How much cash and debt does CC have?

Chemours Company reported $698.00M in cash and cash equivalents and $3.83B of debt on its most recent balance sheet in SEC filings.

How fast is CC revenue growing?

Chemours Company's revenue changed +0.4% in fiscal 2025, to $5.81B. Its compound annual growth rate was +3.2% over 5 years and +0.2% over 10 years.

What is CC gross margin?

Chemours Company's gross profit was $885.00M on $5.84B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 15.2%.

What is CC free cash flow?

Chemours Company generated $211.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $400.00M less capital expenditures.

What is CC earnings per share?

Diluted earnings per share were -$1.02 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did CC last report financial results?

The latest statements here come from Chemours Company's 10-Q filed on Nov 5, 2026, covering the period ended Sep 30, 2026.

Where does this CC financial data come from?

Quantisnow builds these statements from the structured XBRL data Chemours Company files with the SEC. It is provided for information only and is not investment advice.

Financials · CC

Chemours Company (CC) financials

For the twelve months ended Sep 30, 2026, Chemours Company reported $5.84B of revenue and -$154.00M of net income.

Revenue, TTM: $5.84B
Revenue growth, YoY: +0.1%
Net income, TTM: -$154.00M
Net margin: -2.6%
Free cash flow, TTM: $211.00M
EPS, diluted, TTM: -$1.02
Cash: $698.00M
Total debt: $3.83B
P/S: 0.34
Market cap: $2.00B

Annual revenue$5.81B

FY2016FY2025

Annual net income-$386.00M

FY2016FY2025

Annual free cash flow$51.00M

FY2016FY2025

CC revenue and earnings growth

CC revenueQ3 2026$1.54B

Quarter YoY: +3.0%
QoQ: -3.2%
FY YoY: +0.4%
5Y CAGR: +3.2%
10Y CAGR: +0.2%

CC revenue was $1.54B in fiscal Q3 2026 (ended Sep 30, 2026), up 3.0% from a year earlier and down 3.2% from the prior quarter. For the full fiscal 2025 it was $5.81B, up 0.4% from fiscal 2024. Compound annual growth was +3.2% over 5 years and +0.2% over 10 years. It rose in 5 of the last 10 fiscal years.

CC net incomeQ3 2026$196.00M

Quarter YoY: +326.1%

CC net income was $196.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 326.1% from a year earlier. For the full fiscal 2025 it was -$386.00M, compared with $69.00M in fiscal 2024.

CC EPSQ3 2026$1.29

Quarter YoY: +316.1%

CC diluted EPS was $1.29 in fiscal Q3 2026 (ended Sep 30, 2026), up 316.1% from a year earlier. For the full fiscal 2025 it was -$2.57, compared with $0.46 in fiscal 2024.

CC free cash flowQ3 2026$98.00M

Quarter YoY: -6.7%
QoQ: -14.0%
5Y CAGR: -37.6%

CC free cash flow was $98.00M in fiscal Q3 2026 (ended Sep 30, 2026), down 6.7% from a year earlier and down 14.0% from the prior quarter. For the full fiscal 2025 it was $51.00M, compared with -$993.00M in fiscal 2024. Compound annual growth was -37.6% over 5 years.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$5.81B	$5.78B	$6.08B	$6.83B	$6.34B	$4.97B	$5.53B	$6.64B	$6.18B	$5.40B
Cost of revenue	$4.91B	$4.64B	$4.78B	$5.21B	$4.96B	$3.90B	$4.46B	$4.67B	$4.44B	$4.30B
Gross profit	$902.00M	$1.14B	$1.30B	$1.62B	$1.38B	$1.07B	$1.06B	$1.97B	$1.75B	$1.10B
Research and development	$108.00M	$109.00M	$108.00M	$118.00M	$107.00M	$93.00M	$80.00M	$82.00M	$81.00M	$81.00M
Selling, general and admin	$799.00M	$598.00M	$1.29B	$710.00M	$592.00M	$527.00M	$548.00M	$657.00M	$626.00M	$946.00M
Interest expense	$269.00M	$263.00M	$208.00M	$163.00M	$185.00M	$210.00M	$208.00M	$195.00M	$214.00M	$219.00M
Pre-tax income	-$277.00M	$106.00M	-$318.00M	$741.00M	$676.00M	$179.00M	-$124.00M	$1.16B	$912.00M	-$11.00M
Income tax	$109.00M	$37.00M	-$66.00M	$163.00M	$68.00M	-$40.00M	-$72.00M	$159.00M	$165.00M	-$18.00M
Net income	-$386.00M	$69.00M	-$253.00M	$578.00M	$608.00M	$219.00M	-$52.00M	$995.00M	$746.00M	$7.00M
EPS, basic	-$2.57	$0.46	-$1.70	$3.72	$3.69	$1.33	-$0.32	$5.62	$4.04	$0.04
EPS, diluted	-$2.57	$0.46	-$1.70	$3.65	$3.60	$1.32	-$0.32	$5.45	$3.91	$0.04
Diluted shares	150.2M	150.2M	148.9M	158.3M	168.7M	166.3M	164.8M	182.6M	191.0M	183.4M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$670.00M	$763.00M	$1.20B	$1.30B	$1.55B	$1.10B	$943.00M	$1.20B	$1.56B	$902.00M
Receivables	$562.00M	$619.00M	$622.00M	$509.00M	$644.00M	$449.00M	$602.00M	$790.00M	$847.00M	$742.00M
Inventory	$1.57B	$1.46B	$1.35B	$1.40B	$1.10B	$939.00M	$1.08B	$1.15B	$935.00M	$767.00M
Current assets	$3.00B	$3.02B	$3.84B	$3.21B	$3.35B	$2.63B	$2.78B	$3.29B	$3.49B	$2.55B
Goodwill	$46.00M	$46.00M	$102.00M	$102.00M	$102.00M	$153.00M	$153.00M	-	$153.00M	$153.00M
Total assets	$7.38B	$7.51B	$8.24B	$7.64B	$7.55B	$7.08B	$7.26B	$7.36B	$7.29B	$6.06B
Current liabilities	$1.69B	$1.82B	$2.49B	$1.89B	$1.86B	$1.44B	$1.54B	$1.71B	$1.65B	$1.77B
Short-term debt	$42.00M	$54.00M	$51.00M	$43.00M	$25.00M	$21.00M	$134.00M	$13.00M	$15.00M	$15.00M
Long-term debt	$4.10B	$4.06B	$3.99B	$3.59B	$3.72B	$4.00B	$4.03B	$3.96B	$4.10B	$3.53B
Total debt	$4.14B	$4.11B	$4.04B	$3.63B	$3.75B	$4.03B	$4.16B	$3.97B	$4.11B	$3.54B
Total liabilities	$7.13B	$6.94B	$7.52B	$6.53B	$6.47B	$6.27B	$6.56B	$6.34B	$6.43B	$5.96B
Shareholders' equity	$250.00M	$572.00M	$721.00M	$1.11B	$1.08B	$815.00M	$695.00M	$1.02B	$865.00M	$104.00M

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$264.00M	-$633.00M	$556.00M	$755.00M	$814.00M	$807.00M	$650.00M	$1.14B	$640.00M	$594.00M
Capital expenditures	$213.00M	$360.00M	$370.00M	$307.00M	$277.00M	$267.00M	$481.00M	$498.00M	$411.00M	$338.00M
Free cash flow	$51.00M	-$993.00M	$186.00M	$448.00M	$537.00M	$540.00M	$169.00M	$642.00M	$229.00M	$256.00M
Investing cash flow	-$206.00M	-$353.00M	-$229.00M	-$284.00M	$220.00M	-$234.00M	-$483.00M	-$487.00M	-$370.00M	$357.00M
Financing cash flow	-$126.00M	-$36.00M	$172.00M	-$686.00M	-$554.00M	-$449.00M	-$419.00M	-$993.00M	$352.00M	-$396.00M
Dividends paid	$78.00M	$148.00M	$149.00M	$154.00M	$164.00M	$164.00M	$164.00M	$148.00M	$22.00M	$22.00M
Share repurchases	-	-	$69.00M	$495.00M	$173.00M	$0	$322.00M	$644.00M	$106.00M	$0
Stock-based compensation	$21.00M	$15.00M	$18.00M	$27.00M	$34.00M	$16.00M	$19.00M	$24.00M	$29.00M	-
Depreciation and amortization	$340.00M	$292.00M	$309.00M	$291.00M	$317.00M	$320.00M	$311.00M	$284.00M	$273.00M	$284.00M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	0.4%	-4.9%	-11.0%	7.7%	27.7%	-10.1%	-16.8%	7.4%	14.5%	-5.5%
Net income growth, YoY	-	-	-	-4.9%	177.6%	-	-	33.4%	10557.1%	-
EPS growth, YoY	-	-	-	1.4%	172.7%	-	-	39.4%	9675.0%	-
Gross margin	15.5%	19.8%	21.4%	23.7%	21.8%	21.5%	19.2%	29.7%	28.2%	20.4%
Net margin	-6.6%	1.2%	-4.2%	8.5%	9.6%	4.4%	-0.9%	15.0%	12.1%	0.1%
Free cash flow margin	0.9%	-17.2%	3.1%	6.6%	8.5%	10.9%	3.1%	9.7%	3.7%	4.7%
Return on equity	-154.4%	12.1%	-35.1%	52.3%	56.2%	26.9%	-7.5%	97.5%	86.2%	6.7%
Return on assets	-5.2%	0.9%	-3.1%	7.6%	8.1%	3.1%	-0.7%	13.5%	10.2%	0.1%
Current ratio	1.78	1.66	1.55	1.70	1.80	1.83	1.80	1.93	2.12	1.44
Debt to equity	16.56	7.19	5.60	3.28	3.46	4.94	5.99	3.89	4.75	34.08

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Revenue	$1.54B	$1.59B	$1.38B	$1.33B	$1.50B	$1.61B	$1.37B	$1.36B	$1.51B	$1.55B	$1.36B	$1.37B
Cost of revenue	$1.31B	$1.30B	$1.17B	$1.17B	$1.26B	$1.34B	$1.13B	$1.09B	$1.22B	$1.25B	$1.08B	$1.11B
Gross profit	$231.00M	$286.00M	$212.00M	$156.00M	$233.00M	$278.00M	$236.00M	$265.00M	$286.00M	$308.00M	$284.00M	$251.00M
Research and development	$24.00M	$27.00M	$26.00M	$27.00M	$26.00M	$28.00M	$27.00M	$26.00M	$29.00M	$26.00M	$28.00M	$26.00M
Selling, general and admin	-	$469.00M	$147.00M	$130.00M	$122.00M	$424.00M	$123.00M	$170.00M	$137.00M	$154.00M	$137.00M	$219.00M
Interest expense	$69.00M	$68.00M	$69.00M	$68.00M	$68.00M	$67.00M	$66.00M	$67.00M	$68.00M	$66.00M	$63.00M	$63.00M
Pre-tax income	$222.00M	-$1.00M	-$22.00M	-$67.00M	$38.00M	-$248.00M	$0	$1.00M	-$32.00M	$69.00M	$70.00M	-$71.00M
Income tax	$26.00M	$273.00M	$7.00M	-$19.00M	-$8.00M	$131.00M	$5.00M	$12.00M	$0	$9.00M	$16.00M	-$38.00M
Net income	$196.00M	-$274.00M	-$29.00M	-$47.00M	$46.00M	-$380.00M	-$5.00M	-$11.00M	-$32.00M	$60.00M	$54.00M	-$18.00M
EPS, basic	$1.29	-$1.81	-$0.19	-$0.31	$0.31	-$2.53	-$0.03	-$0.08	-$0.22	$0.40	$0.36	-$0.12
EPS, diluted	$1.29	-$1.81	-$0.19	-$0.31	$0.31	-$2.53	-$0.03	-$0.08	-$0.22	$0.39	$0.36	-$0.12
Diluted shares	151.9M	151.2M	150.8M	-	150.8M	150.2M	149.9M	-	149.7M	150.1M	150.1M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Cash and equivalents	$698.00M	$671.00M	$563.00M	$670.00M	$665.00M	$553.00M	$514.00M	$763.00M	$666.00M	$619.00M	$1.35B	$1.20B
Receivables	$765.00M	$773.00M	$645.00M	$562.00M	$817.00M	$813.00M	$704.00M	$619.00M	$825.00M	$906.00M	$813.00M	$622.00M
Inventory	$1.48B	$1.45B	$1.54B	$1.57B	$1.55B	$1.56B	$1.55B	$1.46B	$1.43B	$1.36B	$1.38B	$1.35B
Current assets	$3.22B	$3.09B	$2.93B	$3.00B	$3.21B	$3.10B	$2.93B	$3.02B	$3.08B	$2.94B	$3.61B	$3.84B
Goodwill	$46.00M	$46.00M	$46.00M	$46.00M	$46.00M	$46.00M	$46.00M	$46.00M	$46.00M	$102.00M	$102.00M	$102.00M
Total assets	$7.29B	$7.15B	$7.27B	$7.38B	$7.55B	$7.46B	$7.38B	$7.51B	$7.46B	$7.25B	$7.98B	$8.24B
Current liabilities	$1.78B	$1.86B	$1.61B	$1.69B	$1.87B	$1.83B	$1.67B	$1.82B	$1.79B	$1.56B	$2.23B	$2.49B
Short-term debt	$50.00M	$34.00M	$37.00M	$42.00M	$52.00M	$38.00M	$43.00M	$54.00M	$53.00M	$37.00M	$41.00M	$51.00M
Long-term debt	$3.78B	$3.84B	$4.10B	$4.10B	$4.10B	$4.11B	$4.07B	$4.06B	$3.99B	$3.95B	$3.97B	$3.99B
Total debt	$3.83B	$3.87B	$4.14B	$4.14B	$4.16B	$4.15B	$4.11B	$4.11B	$4.04B	$3.99B	$4.01B	$4.04B
Total liabilities	$7.14B	$7.20B	$7.05B	$7.13B	$7.27B	$7.23B	$6.81B	$6.94B	$6.81B	$6.53B	$7.23B	$7.52B
Shareholders' equity	$155.00M	-$48.00M	$216.00M	$250.00M	$276.00M	$230.00M	$567.00M	$572.00M	$645.00M	$716.00M	$755.00M	$721.00M

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Operating cash flow	$149.00M	$158.00M	-$44.00M	$137.00M	$146.00M	$93.00M	-$112.00M	$138.00M	$139.00M	-$620.00M	-$290.00M	$482.00M
Capital expenditures	$51.00M	$44.00M	$49.00M	$45.00M	$41.00M	$43.00M	$84.00M	$109.00M	$76.00M	$73.00M	$102.00M	$135.00M
Free cash flow	$98.00M	$114.00M	-$93.00M	$92.00M	$105.00M	$50.00M	-$196.00M	$29.00M	$63.00M	-$693.00M	-$392.00M	$347.00M
Investing cash flow	-$7.00M	$239.00M	-$44.00M	-$43.00M	-$35.00M	-$42.00M	-$86.00M	-$107.00M	-$75.00M	-$70.00M	-$101.00M	-$130.00M
Financing cash flow	-$63.00M	-$289.00M	-$19.00M	-$37.00M	-$5.00M	-$27.00M	-$57.00M	$85.00M	-$27.00M	-$40.00M	-$54.00M	-$5.00M
Dividends paid	$13.00M	$13.00M	$13.00M	$15.00M	$13.00M	$13.00M	$37.00M	$36.00M	$38.00M	$37.00M	$37.00M	$37.00M
Share repurchases	-	-	-	-	-	-	-	-	-	-	-	$0
Stock-based compensation	$4.00M	$7.00M	$7.00M	$4.00M	$5.00M	$7.00M	$5.00M	$3.00M	$5.00M	$6.00M	$1.00M	$5.00M
Depreciation and amortization	$79.00M	$80.00M	$79.00M	$81.00M	$80.00M	$91.00M	$88.00M	$74.00M	$73.00M	$74.00M	$71.00M	$76.00M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Revenue growth, YoY	3.0%	-1.5%	1.0%	-2.2%	-0.9%	3.9%	0.4%	-0.7%	0.5%	-6.4%	-12.1%	2.2%
Net income growth, YoY	326.1%	-	-	-	-	-	-	-	-	-	-62.8%	-
EPS growth, YoY	316.1%	-	-	-	-	-	-	-	-	-	-62.5%	-
Gross margin	15.0%	18.0%	15.4%	11.7%	15.6%	17.2%	17.3%	19.5%	19.0%	19.8%	20.9%	18.3%
Net margin	12.7%	-17.2%	-2.1%	-3.5%	3.1%	-23.5%	-0.4%	-0.8%	-2.1%	3.9%	4.0%	-1.3%
Free cash flow margin	6.4%	7.2%	-6.7%	6.9%	7.0%	3.1%	-14.3%	2.1%	4.2%	-44.6%	-28.8%	25.4%
Current ratio	1.81	1.66	1.82	1.78	1.71	1.70	1.76	1.66	1.72	1.88	1.62	1.55
Debt to equity	24.73	-	19.15	16.56	15.06	18.03	7.25	7.19	6.27	5.57	5.31	5.60

Source: XBRL data Chemours Company files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CC peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CC	$5.84B	+0.1%	-$154.00M	-2.6%	$2.00B
LINLinde plc	$36.24B	+8.2%	$7.01B	19.3%	$238.88B
APDAir Products and Chemicals Inc.	$12.60B	+4.5%	-$47.30M	-0.4%	$69.27B
DOWDow Inc.	$42.61B	+4.2%	-$897.00M	-2.1%	$22.41B
IFFInternational Flavors & Fragrances Inc.	$11.69B	+24.3%	$182.00M	1.6%	$21.14B
DDDuPont de Nemours Inc.	$7.06B	+3.2%	$301.00M	4.3%	$20.56B
LYBLyondellBasell Industries NV	$31.96B	+3.5%	$1.30B	4.1%	$19.23B
ALBAlbemarle Corporation	$6.15B	+24.4%	$681.63M	11.1%	$11.70B
SOLSSolstice Advanced Materials Inc.	$4.17B	+9.4%	$325.00M	7.8%	$10.01B

CC FAQ

9 questions

What is CC revenue?
Chemours Company (CC) reported $5.84B of revenue for the twelve months ended Sep 30, 2026. That is up 0.1% from the year before. Revenue for fiscal 2025 was $5.81B.
Is CC profitable?
No. Chemours Company reported a net loss of $154.00M for the twelve months ended Sep 30, 2026.
How much cash and debt does CC have?
Chemours Company reported $698.00M in cash and cash equivalents and $3.83B of debt on its most recent balance sheet in SEC filings.
How fast is CC revenue growing?
Chemours Company's revenue changed +0.4% in fiscal 2025, to $5.81B. Its compound annual growth rate was +3.2% over 5 years and +0.2% over 10 years.
What is CC gross margin?
Chemours Company's gross profit was $885.00M on $5.84B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 15.2%.
What is CC free cash flow?
Chemours Company generated $211.00M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $400.00M less capital expenditures.
What is CC earnings per share?
Diluted earnings per share were -$1.02 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did CC last report financial results?
The latest statements here come from Chemours Company's 10-Q filed on Nov 5, 2026, covering the period ended Sep 30, 2026.
Where does this CC financial data come from?
Quantisnow builds these statements from the structured XBRL data Chemours Company files with the SEC. It is provided for information only and is not investment advice.